-
International Journal of Women's Health
- About Dovepress
Open access peer-reviewed scientific and medical journals.
- Open Access
Dove Medical Press is now a member of the Open Access Initiative
- An Author's Guide
A guide to help authors get their paper published.
- Advocacy
Support Open Access and Dove Press
- Reprints
Promotional Article Monitoring - further details
- Favored Author Program
Real benefits for authors, including fast-track processing of papers.
Women’s awareness and periconceptional use of folic acid: data from a large European survey
Original Research
(2961) Total Article Views
Authors: Bitzer J, von Stenglin A, Bannemerschult R
Published Date April 2013 Volume 2013:5 Pages 201 - 213
DOI: http://dx.doi.org/10.2147/IJWH.S40149
Received: | 09 November 2012 |
---|---|
Accepted: | 18 January 2013 |
Published: | 26 April 2013 |
1Department of Obstetrics and Gynecology, University Women’s Hospital of Basel, Basel, Switzerland; 2Global Market Research, Bayer HealthCare Pharmaceuticals, Berlin, Germany; 3Women’s Healthcare Medical Affairs and Pharmacovigilance Region Europe, Bayer HealthCare Pharmaceuticals, Berlin, Germany
Objective: To investigate the awareness and use of folic acid in European women of child-bearing age, particularly in the setting of pregnancy and pregnancy planning.
Methods: Between November 2009 and December 2009, women aged 15–49 years old from 18 European countries completed a 30-minute structured questionnaire either online or via face-to-face interviews. To achieve nationally representative samples for each country quotas were set for age, education, income, and regional distribution.
Results: A total of 22,925 women participated in the survey. Of the respondents, 58% had at least one biological child, and of these 38% reported that their first pregnancy was not planned. Nearly 60% of women who planned their pregnancy indicated that they had stopped using their method of contraception without first consulting a doctor or another health care professional. Overall, 70% reported that they had heard of folic acid and 40% stated that they knew the benefits of folic acid. However, when prompted to indicate which diseases and/or birth defects folic acid can protect against, only 17% knew that folic acid can reduce the risk of neural tube defects/spina bifida.
Conclusions: A large proportion of European women of child-bearing age in this survey were unaware that periconceptional folic acid supplementation reduces the risk of birth defects.
Keywords: folic acid supplementation, neural tube defects, pregnancy, women, periconceptional period, survey
Post to:
Cannotea Citeulike Del.icio.us Facebook LinkedIn Twitter
Other articles by Professor Johannes Bitzer
Readers of this article also read:
- Testimonials
"You do a tremendous job!!" Ruben Restrepo, University of Texas Health Science Center, San Antonio.
- Tinidazole in the treatment of bacterial vaginosis
- Antibacterial treatment of bacterial vaginosis: current and emerging therapies
- Contraceptive practices in Nigeria: Literature review and recommendation for future policy decisions
- Vaginal rings for delivery of HIV microbicides